BioTech Sphere Research, a unit of NeoNexus Healthcare Pvt Ltd, is leading a transformative wave in rare disease research, especially in underserved regions of India. Through its flagship initiative, Project Phoenix, the organization integrates global research networks with grassroots healthcare innovation. Its recent collaborations with GA4GH and contributions to Springer Nature and Taylor & Francis publications mark a major leap in rare disease diagnostics and genomic literacy. By establishing the Meerut Rare Disease Research Hub and engaging with over 70 countries, BioTech aims to democratize access to digital and precision medicine. This story highlights a blueprint for inclusive, tech-powered healthcare solutions in low-resource settings.
BioTech Sphere Research, a unit of NeoNexus Healthcare Pvt Ltd, is making waves in global healthcare with its deepening commitment to rare disease research, particularly for underserved populations in India and beyond. Under the umbrella of its flagship initiative Project Phoenix, the organization is breaking ground by combining grassroots healthcare innovation with international research collaboration.
In partnership with the Global Alliance for Genomics and Health (GA4GH), BioTech Sphere Research is actively contributing to the Rare Disease Workstream — a collaborative network that drives ethical, interoperable genomic research frameworks worldwide.
This vision aligns with BioTech’s broader goal: bringing early diagnostics, genomic literacy, and digital monitoring tools to Tier 3 and Tier 4 cities, often overlooked in national healthcare programs.
“We believe the future of rare disease diagnostics lies in real-time rural data, community ownership, and global collaboration.”
— Aryan Chaudhary, Director, BioTech Sphere Research
BioTech’s dedication to impactful research is backed by significant academic and data-driven achievements:
Additionally, BioTech is a signatory of the San Francisco Declaration on Research Assessment (DORA), reinforcing its commitment to responsible metrics and transparent science dissemination.
BioTech Sphere Research has officially published its first peer-reviewed review paper with Springer Nature, marking a milestone in its formal scientific contributions to global rare disease literature.
Further extending its impact, the organization has also contributed to an upcoming Taylor & Francis book series centered on innovations in precision medicine and rural healthcare transformation.
These milestones affirm BioTech’s positioning as a thought leader in merging health equity, technology, and community-led healthcare models.
Through its academic collaboration with the Meerut ACM Professional Chapter, BioTech has established the Meerut Rare Disease Hub — a center focused on computational biology, epidemiology, and smart diagnostics for low-resource environments. This interdisciplinary hub is working closely with local institutions and data scientists to unlock new insights into rare, chronic, and environmental-linked diseases.
BioTech Sphere Research is proudly affiliated with major global and national initiatives, including:
These partnerships amplify the reach and credibility of BioTech’s mission to democratize research access and data utility for rural populations.
BioTech Sphere Research invites collaborations from researchers, digital health innovators, and policy organizations focused on rare diseases, digital therapeutics, and inclusive health access.
